中文名 | TOLAZAMIDE |
英文名 | 1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea |
别名 | 妥拉磺脲 妥拉磺尿 甲磺氮草脲 妥拉磺脲 USP标准品 妥拉磺脲溶液,100PPM 妥拉磺脲TOLAZAMIDE N-(氮杂卓-1-基氨基甲酰基)-4-甲基苯磺酰胺 1-(4-甲苯磺酰基)-3-(六氢-1H-吖庚因-1-基)脲 |
英文别名 | diabewas NSC 70762 TOLAZAMIDE Tolazamide Solution, 100ppm 1-(hexahydro-1-azepinyl)-3-p-tolylsulfonylurea 1-(azepan-1-yl)-3-(4-methylphenyl)sulfonylurea 4-(p-tolylsulfonyl)-1,1-hexamethylenesemicarbazide 1-(hexahydro-1h-azepin-1-yl)-3-(p-tolylsulfonyl)-ure 1-(hexahydro-1h-azepin-1-yl)-3-(p-tolylsulfonyl)urea 1-(4-Methylphenylsulfonyl)-3-(hexahydro-1H-azepin-1-yl)urea |
CAS | 1156-19-0 |
EINECS | 214-588-3 |
化学式 | C14H21N3O3S |
分子量 | 311.4 |
密度 | 1.2228 (rough estimate) |
熔点 | 162-164°C |
沸点 | 300°C (rough estimate) |
水溶性 | 65.4mg/L(30 ºC) |
溶解度 | 极微溶于水; 易溶于氯仿; 溶于丙酮; 微溶于乙醇 (96%)。 |
折射率 | 1.6740 (estimate) |
酸度系数 | 3.6(at 25℃) |
存储条件 | Sealed in dry,Room Temperature |
外观 | 固体 |
颜色 | White to Off-White |
靶点 | Potassium Channel |
危险品标志 | Xn - 有害物品![]() |
风险术语 | 22 - 吞食有害。 |
安全术语 | 36 - 穿戴适当的防护服。 |
WGK Germany | 3 |
RTECS | YT4400000 |
海关编号 | 2935904000 |
上游原料 | 氢化铝锂 |
参考资料 展开查看 | 1: Boldyreva EV, Arkhipov SG, Drebushchak TN, Drebushchak VA, Losev EA, Matvienko AA, Minkov VS, Rychkov DA, Seryotkin YV, Stare J, Zakharov BA. Isoenergetic Polymorphism: The Puzzle of Tolazamide as a Case Study. Chemistry. 2015 Oct 19;21(43):15395-404. doi: 10.1002/chem.201501541. Epub 2015 Sep 4. PubMed PMID: 26337712. 2: Gao Y, Olsen KW. Drug-polymer interactions at water-crystal interfaces and implications for crystallization inhibition: molecular dynamics simulations of amphiphilic block copolymer interactions with tolazamide crystals. J Pharm Sci. 2015 Jul;104(7):2132-41. doi: 10.1002/jps.24442. Epub 2015 Jun 4. PubMed PMID: 26045147. 3: Schmitt JK, Johns SB. Altering therapy of type II diabetes mellitus from insulin to tolazamide increases blood pressure in spite of weight loss. Am J Hypertens. 1995 May;8(5 Pt 1):520-3. PubMed PMID: 7662230. 4: Sanders R, Faro B, Stoler P, Mick GJ, McCormick KL. Adjunctive use of tolazamide in newly-diagnosed diabetic children. Horm Metab Res. 1990 Nov;22(11):576-80. PubMed PMID: 2272604. 5: Lev JD, Zeidler A, Kumar D. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide. Diabetes Care. 1987 Nov-Dec;10(6):679-82. PubMed PMID: 3123183. 6: Firth R, Bell P, Marsh M, Rizza RA. Effects of tolazamide and exogenous insulin on pattern of postprandial carbohydrate metabolism in patients with non-insulin-dependent diabetes mellitus. Results of randomized crossover trial. Diabetes. 1987 Oct;36( |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.211 ml | 16.057 ml | 32.113 ml |
5 mM | 0.642 ml | 3.211 ml | 6.423 ml |
10 mM | 0.321 ml | 1.606 ml | 3.211 ml |
5 mM | 0.064 ml | 0.321 ml | 0.642 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!